Testing the efficacy of AR degrading compounds in enzalutamide-resistant prostate cancer
Research Grant
Administered By
Medicine, Medical Oncology
Awarded By
Arvinas Inc.
Start Date
January 5, 2017
End Date
January 8, 2019
Administered By
Medicine, Medical Oncology
Awarded By
Arvinas Inc.
Start Date
January 5, 2017
End Date
January 8, 2019